IdentificationGeneric Name(2R)-2-{(1R)-2-oxo-1-[(2-thienylacetyl)amino]ethyl}-5,6-dihydro-2h-1,3-thiazine-4-carboxylic acidDrugBank Accession NumberDB04742BackgroundNot AvailableTypeSmall MoleculeGroupsExperimentalStructure


3DDownload MOLSDF3D-SDFPDBSMILESInChI


 Similar StructuresStructure for (2R)-2-{(1R)-2-oxo-1-[(2-thienylacetyl)amino]ethyl}-5,6-dihydro-2h-1,3-thiazine-4-carboxylic acid (DB04742)× CloseWeightAverage: 326.391 Monoisotopic: 326.039498326 Chemical FormulaC13H14N2O4S2SynonymsNot AvailablePharmacologyIndicationNot AvailableReduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.See how  Build, train, & validate predictive machine-learning models with structured datasets.See howContraindications & Blackbox WarningsAvoid life-threatening adverse drug eventsImprove clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Learn more  Avoid life-threatening adverse drug events & improve clinical decision support.Learn morePharmacodynamicsNot AvailableMechanism of actionTargetActionsOrganismUD-alanyl-D-alanine carboxypeptidaseNot AvailableActinomadura sp. (strain R39)AbsorptionNot AvailableVolume of distributionNot AvailableProtein bindingNot AvailableMetabolismNot AvailableRoute of eliminationNot AvailableHalf-lifeNot AvailableClearanceNot AvailableAdverse EffectsImprove decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.Learn more  Improve decision support & research outcomes with our structured adverse effects data.Learn moreToxicityNot AvailablePathwaysNot AvailablePharmacogenomic Effects/ADRs 


Not AvailableInteractionsDrug Interactions 


This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist. Not AvailableFood InteractionsNot AvailableCategoriesDrug CategoriesNot AvailableChemical TaxonomyProvided by ClassyfireDescriptionThis compound belongs to the class of organic compounds known as 1,3-thiazines. These are organic compounds containing 1,3-thiazine, a six-member ring with a nitrogen and a sulfur atoms in ring positions 1 and 3 respectively, as well as two double bonds.KingdomOrganic compoundsSuper ClassOrganoheterocyclic compoundsClassThiazinesSub Class1,3-thiazinesDirect Parent1,3-thiazinesAlternative ParentsThiophenes / Heteroaromatic compounds / Secondary carboxylic acid amides / Ketimines / Propargyl-type 1,3-dipolar organic compounds / Monocarboxylic acids and derivatives / Dialkylthioethers / Carboxylic acids / Azacyclic compounds / Organopnictogen compounds / Organic oxides / Hydrocarbon derivatives / Aldehydes


 show 3 moreSubstituentsAldehyde / Aromatic heteromonocyclic compound / Azacycle / Carbonyl group / Carboxamide group / Carboxylic acid / Carboxylic acid derivative / Dialkylthioether / Heteroaromatic compound / Hydrocarbon derivative / Imine / Ketimine / Meta-thiazine / Monocarboxylic acid or derivatives / Organic 1,3-dipolar compound / Organic nitrogen compound / Organic oxide / Organic oxygen compound / Organonitrogen compound / Organooxygen compound / Organopnictogen compound / Propargyl-type 1,3-dipolar organic compound / Secondary carboxylic acid amide / Thioether / Thiophene


 show 15 moreMolecular FrameworkAromatic heteromonocyclic compoundsExternal Descriptorsthiazinemonocarboxylic acid (CHEBI:44267) Affected organismsNot AvailableChemical IdentifiersUNIINot AvailableCAS numberNot AvailableInChI KeyQIZKCGBBVPUBJL-ZYHUDNBSSA-NInChIInChI=1S/C13H14N2O4S2/c16-7-10(12-15-9(13(18)19)3-5-21-12)14-11(17)6-8-2-1-4-20-8/h1-2,4,7,10,12H,3,5-6H2,(H,14,17)(H,18,19)/t10-,12-/m1/s1IUPAC Name(2R)-2-[(1R)-2-oxo-1-[2-(thiophen-2-yl)acetamido]ethyl]-5,6-dihydro-2H-1,3-thiazine-4-carboxylic acidSMILES[H][C@@](NC(=O)CC1=CC=CS1)(C=O)[C@@]1([H])SCCC(=N1)C(O)=OReferencesGeneral ReferencesNot AvailableExternal LinksPubChem Compound5288990PubChem Substance46505603ChemSpider4451047ZINCZINC000012504489PDBe LigandNCFPDB Entries1w8yClinical TrialsClinical Trials 


PhaseStatusPurposeConditionsCountPharmacoeconomicsManufacturersNot AvailablePackagersNot AvailableDosage FormsNot AvailablePricesNot AvailablePatentsNot AvailablePropertiesStateSolidExperimental PropertiesNot AvailablePredicted PropertiesPropertyValueSourceWater Solubility0.0551 mg/mLALOGPSlogP0.93ALOGPSlogP1.43ChemaxonlogS-3.8ALOGPSpKa (Strongest Acidic)3.57ChemaxonpKa (Strongest Basic)-1.5ChemaxonPhysiological Charge-1ChemaxonHydrogen Acceptor Count5ChemaxonHydrogen Donor Count2ChemaxonPolar Surface Area95.83 Å2ChemaxonRotatable Bond Count6ChemaxonRefractivity78.94 m3·mol-1ChemaxonPolarizability30.73 Å3ChemaxonNumber of Rings2ChemaxonBioavailability1ChemaxonRule of FiveYesChemaxonGhose FilterYesChemaxonVeber's RuleNoChemaxonMDDR-like RuleNoChemaxonPredicted ADMET FeaturesPropertyValueProbabilityHuman Intestinal Absorption-0.9358Blood Brain Barrier-0.6466Caco-2 permeable-0.7235P-glycoprotein substrateSubstrate0.5P-glycoprotein inhibitor INon-inhibitor0.9593P-glycoprotein inhibitor IINon-inhibitor0.9912Renal organic cation transporterNon-inhibitor0.81CYP450 2C9 substrateNon-substrate0.7996CYP450 2D6 substrateNon-substrate0.8192CYP450 3A4 substrateNon-substrate0.6767CYP450 1A2 substrateNon-inhibitor0.8259CYP450 2C9 inhibitorNon-inhibitor0.9007CYP450 2D6 inhibitorNon-inhibitor0.911CYP450 2C19 inhibitorNon-inhibitor0.9152CYP450 3A4 inhibitorNon-inhibitor0.9103CYP450 inhibitory promiscuityLow CYP Inhibitory Promiscuity0.9561Ames testNon AMES toxic0.8375CarcinogenicityNon-carcinogens0.9457BiodegradationNot ready biodegradable0.8685Rat acute toxicity2.1491 LD50, mol/kg Not applicablehERG inhibition (predictor I)Weak inhibitor0.9954hERG inhibition (predictor II)Non-inhibitor0.9364  ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397) SpectraMass Spec (NIST)Not AvailableSpectraSpectrumSpectrum TypeSplash KeyPredicted GC-MS Spectrum - GC-MSPredicted GC-MSNot AvailablePredicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSNot AvailableTargetsBuild, predict & validate machine-learning modelsUse our structured and evidence-based datasets to unlock newinsights and accelerate drug research.Learn more  Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.Learn more


 Details1. D-alanyl-D-alanine carboxypeptidaseKindProteinOrganismActinomadura sp. (strain R39)Pharmacological actionUnknownGeneral FunctionSerine-type d-ala-d-ala carboxypeptidase activitySpecific FunctionRemoves C-terminal D-alanyl residues from sugar-peptide cell wall precursors.Gene NamedacUniprot IDP39045Uniprot NameD-alanyl-D-alanine carboxypeptidaseMolecular Weight54973.425 DaReferencesBerman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [Article] ×Identify potential medication risksEasily compare up to 40 drugs with our drug interaction checker.Get severity rating, description, and management advice. Learn more   Drug created at September 11, 2007 17:49 / Updated at June 12, 2020 16:52 